Navigation Links
Next Generation Protein Sequencing Company Rapid Novor Enters into New Phase of Growth
Date:10/3/2019

Rapid Novor, Inc., the world's leader in antibody protein sequencing using mass spectrometry, is pleased to announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now home to four proteomics-grade mass spectrometers among other analytical instruments, the new facility demonstrates the company's continuous commitment to quality research and service offerings.

The new facility is located at Catalyst 137, an innovation hub hosting the best and the brightest high growth companies in the Kitchener-Waterloo region. The company's new space includes a mass spectrometry lab, a biochemistry lab and a large open office area, where people from all disciplines collaborate, communicate, learn and innovate without barriers.

"Moving into the new facility is a significant milestone for the company. The new facility provides the space and infrastructure we need for our next phase of growth,” says Mingjie Xie, co-founder and CEO. "When designing the new space, we always kept one thing in mind, that our new home must continue to foster and facilitate open communication, collaboration and innovation. This is part of our core value."

"We have tripled the lab space in our new facility," says Dr. Bin Ma, co-founder and Chief Scientist. "The larger space will allow us to host more equipment and have a larger team conducting research experiments at the same time. This, in turn, will provide higher throughput for both our services and innovation."

About Rapid Novor, Inc.

Rapid Novor, Inc. is the world's leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing access to the producing cell line. As a University of Waterloo spin-off, the company continues to build its technology portfolios based on the twenty years of scientific research and inventions from Dr. Bin Ma, co-founder and chief scientist. The company's REmAb™ antibody protein sequencing service has allowed for the accurate sequencing of any given antibody proteins on a routine basis in high throughput manner. The company's WILD™ service is the first commercially available service that can accurately distinguish the isobaric Isoleucine and Leucine using mass spectrometry. For more information, please visit https://www.rapidnovor.com. Follow the company on Twitter @rapidnovor and LinkedIn https://www.linkedin.com/company/rapid-novor-inc/.

Read the full story at https://www.prweb.com/releases/next_generation_protein_sequencing_company_rapid_novor_enters_into_new_phase_of_growth/prweb16614215.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Consider Corn Challenge Winners Focus on Improving Existing Products in the Marketplace with Corn Based Next Generation Renewable Materials
2. Murrieta Genomics and SeqOnce Biosciences Team to Simplify and Commercialize Next Generation Sequencing Sample Preparation
3. Nanoscience Instruments Introduces the Phenom Pro and ProX Generation 5 SEMs
4. Thermo Fisher Scientific Shares Applications of Targeted Next-generation Sequencing Panels in Neurodevelopmental Disorder Research
5. Miltenyi Biotec Showcases the Generation of Purified Human iPSC Derived Cardiomyocytes
6. MSP Corporation Announces a New Breakthrough in Monodisperse Droplet Generation
7. METTLER TOLEDO Launches New Generation of Multi-Parameter M400 Transmitter
8. Next-Generation Sequencing (NGS) Market Growing at a CAGR of 20.5% During 2017 to 2022 - ReportsnReports
9. Research and Markets - $5.3 Billion Next Generation Sequencing Markets, 2016-2020: Focus on Systems, Consumables, Services, Competitive Analysis, Trends, Platforms
10. Global $7.52 Billion Next Generation Sequencing Market Assessment & Forecast: 2017-2021 - Opportunities in Reagents and Consumables Segment - Research and Markets
11. Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):